National Bank of Canada
NNVC icon

National Bank of Canada’s NanoViricides NNVC Stock Holding History

National Bank of Canada’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46 Hold
50
– – ﹤0.01% 2871
2025
Q4 		$56 Buy
+50
New +$70 ﹤0.01% 2810

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

National Bank of Canada's NNVC Position: Q1 2026 in Review

National Bank of Canada held its NanoViricides (NNVC) position steady in Q1 2026 at 50 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

National Bank of Canada first reported a position in NNVC in Q4 2025 and has held it in 2 quarters since. The position peaked at $56 in Q4 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • National Bank of Canada held 50 shares of NanoViricides worth $46 as of Q1 2026.
  • National Bank of Canada left its NanoViricides share count unchanged in Q1 2026.
  • NanoViricides made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2871 holding.
  • National Bank of Canada first reported a position in NanoViricides in Q4 2025 and has held it in 2 quarters since.
  • National Bank of Canada's NanoViricides position peaked at $56 in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.